Skip to main content

Edwards Lifesciences Corp United States revenue

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

United States revenue at Edwards Lifesciences Corp came to $1.0B for the quarter to 30 Sep 2026, up 11.0% from a year earlier.

As Edwards Lifesciences Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$744.3MDec 2023$782.1MMar 2024$806.4MJun 2024$804.6MSep 2024$812.9MDec 2024$838.9MMar 2025$889.7MJun 2025$907.5MSep 2025$907.0MDec 2025$937.6MMar 2026$1.0BJun 2026$1.0BSep 2026
Edwards Lifesciences Corp United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
30 Sep 2026$1.0Bup 11.0%4 Nov 2026
30 Jun 2026$1.0Bup 12.8%4 Aug 2026
31 Mar 2026$937.6Mup 11.8%6 May 2026
31 Dec 2025$907.0Mup 11.6%25 Feb 2026
30 Sep 2025$907.5Mup 12.8%5 Nov 2025
30 Jun 2025$889.7Mup 10.3%6 Aug 2025
31 Mar 2025$838.9Mup 7.3%6 May 2025
31 Dec 2024$812.9Mup 9.2%28 Feb 2025
30 Sep 2024$804.6Mup 9.3%6 Nov 2024
30 Jun 2024$806.4Mup 5.8%31 Jul 2024
31 Mar 2024$782.1Mdown 7.9%29 Apr 2024
31 Dec 2023$744.3Mdown 6.4%12 Feb 2024
30 Sep 2023$735.9Mdown 6.5%27 Oct 2023
30 Jun 2023$761.9Mdown 4.9%28 Jul 2023
31 Mar 2023$849.1Mup 13.3%28 Apr 2023
31 Dec 2022$795.5Mup 7.6%13 Feb 2023
30 Sep 2022$786.8Mup 4.4%28 Oct 2022
30 Jun 2022$800.8Mup 0.6%29 Jul 2022
31 Mar 2022$749.5Mup 11.1%28 Apr 2022
31 Dec 2021$739.4Mup 10.2%14 Feb 2022
30 Sep 2021$753.3Mup 13.8%29 Oct 2021
30 Jun 2021$795.7Mup 54.1%30 Jul 2021
31 Mar 2021$674.7Mup 1.1%28 Apr 2021
31 Dec 2020$671.2Mdown 3.7%12 Feb 2021
30 Sep 2020$662.0Mup 2.2%26 Oct 2020
30 Jun 2020$516.2Mdown 17.4%27 Jul 2020
31 Mar 2020$667.4Mup 18.6%28 Apr 2020
31 Dec 2019$697.2Mup 27.9%14 Feb 2020
30 Sep 2019$647.8Mup 24.9%25 Oct 2019
30 Jun 2019$624.9Mup 22.0%26 Jul 2019
31 Mar 2019$562.8Mup 17.4%26 Apr 2019
31 Dec 2018$545.0M—15 Feb 2019
30 Sep 2018$518.5Mup 10.2%26 Oct 2018
30 Jun 2018$512.2Mup 7.0%27 Jul 2018
31 Mar 2018$479.5M—27 Apr 2018
30 Sep 2017$470.4M—27 Oct 2017
30 Jun 2017$478.9M—28 Jul 2017
30 Jun 2013$240.5Mup 16.2%6 Aug 2013
31 Mar 2013$227.9Mup 22.1%6 May 2013
31 Dec 2012$225.0Mup 45.4%28 Feb 2013

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Edwards Lifesciences Corp: Transcatheter Aortic Valve Replacement revenue · Surgical revenue · Transcatheter Mitral and Tricuspid Therapies revenue · Europe revenue · Rest of World revenue · Japan revenue · financial statements

Every KPI and segment of EW, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.